Winship Cancer Institute’s Carlos Moreno has a sharply written commentary on Reuters, whipping Big Pharma for footdragging on cancer drug discovery for patent/IP-related reasons. Check it out.
- Search
- Updates by Email
-
Latest Posts
- Emory Blogs
- Related Links
- Meta